Reduced Effectiveness of Contraceptive Implants for Women Taking the Antiretroviral Efavirenz (EFV) : Still Good Enough and for how Long?
Shelton, J.D.
Global Health Science and Practice 3(4): 528-531
2015
ISSN/ISBN: 2169-575X PMID: 26681700 DOI: 10.9745/ghsp-d-15-00356Document Number: 641948
Document emailed within 0-6 h
Related Documents
Morroni, C.; Bekker, L.-G.; Rees, H. 2015: Contraceptive implants and efavirenz-based ART: friend or foe? LANCET. HIV 2(11): E454-E455Morroni, C.; Bekker, L.-G.; Rees, H. 2015: Contraceptive implants and efavirenz-based ART: friend or foe? LANCET. HIV 2(11): E454-E455
Scarsi, K.; Lamorde, M.; Darin, K.; Penchala, S.D.; Else, L.; Nakalema, S.; Byakika-Kibwika, P.; Khoo, S.; Cohn, S.; Merry, C.; Back, D. 2014: Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant Journal of the International Aids Society 17(4 Suppl 3: 19484
Ouattara, E.N.; Anglaret, X.; Wong, A.Y.; Chu, J.; Hsu, H.E.; Danel, C.; Eholié, S.; Moh, R.; Gabillard, D.; Walensky, R.P.; Freedberg, K.A. 2012: Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age Aids 26(5): 625-634
Vieira, C.S.; Bahamondes, M.V.; de Souza, R.M.; Brito, M.B.; Rocha Prandini, T.R.; Amaral, E.; Bahamondes, L.; Duarte, G.; Quintana, S.M.; Scaranari, C.; Ferriani, R.A. 2014: Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women Journal of Acquired Immune Deficiency Syndromes 66(4): 378-385
Narula, R.K.; Chandra, V.L.; Dugwekar, Y.G.; Rahman, S.A.; Laumas, K.R. 1975: Long-term contraception by steroid releasing implants. III. Mode of action of megestrol acetate (MA) administered by subcutaneous silastic implants in women Indian Journal of Medical Research 63(11): 1620-1628
Narula, R.K.; Chandra, V.L.; Dugwekar, Y.G.; Rahman, S.A.; Laumas, K.R. 1975: Long-term contraception by steroid releasing implants. III. Mode of action of megestrol acetate (MA) administered by subcutaneous silastic implants in women Indian Journal of Medical Research 63(11): 1620-1628
Patel, R.C.; Onono, M.; Gandhi, M.; Blat, C.; Hagey, J.; Shade, S.B.; Vittinghoff, E.; Bukusi, E.A.; Newmann, S.J.; Cohen, C.R. 2015: Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study Lancet. HIV 2(11): E474-E482
Chu, J.H.; Gange, S.J.; Anastos, K.; Minkoff, H.; Cejtin, H.; Bacon, M.; Levine, A.; Greenblatt, R.M. 2005: Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy American Journal of Epidemiology 161(9): 881-890
Nanda, K.; Delany-Moretlwe, S.; Dubé, K.; Lendvay, A.; Kwok, C.; Molife, L.; Nakubulwa, S.; Edward, V.A.; Mpairwe, B.; Mirembe, F.M. 2013: Nevirapine-based antiretroviral therapy does not reduce oral contraceptive effectiveness Aids 27(Suppl 1): S17-S25
Whiteman, M.K.; Jeng, G.; Samarina, A.; Akatova, N.; Martirosyan, M.; Kissin, D.M.; Curtis, K.M.; Marchbanks, P.A.; Hillis, S.D.; Mandel, M.G.; Jamieson, D.J. 2016: Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness Contraception 93(1): 17-24
Bhattacharyya, S.; Srivastava, A.; Avan, B.I. 2013: Delivery should happen soon and my pain will be reduced: understanding women's perception of good delivery care in India Global Health Action 6: 22635
Gisslén, M.; Sönnerborg, A. 2002: Swedish guidelines for antiretroviral treatment of HIV. Good compliance is crucial for a good result Lakartidningen 99(43): 4263-4266
Massai, M.R.; Díaz, S.; Quinteros, E.; Reyes, M.V.; Herreros, C.; Zepeda, A.; Croxatto, H.B.; Moo-Young, A.J. 2001: Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women Contraception 64(6): 369-376
Greenberg, K.B.; Jenks, S.C.; Piazza, N.; Malibiran, B.R.; Aligne, C.A. 2017: A Snapshot of Urban Adolescent Women's Contraceptive Knowledge at the Onset of a Community Long-Acting Reversible Contraceptive Promotion Initiative Journal of Pediatric and Adolescent Gynecology 30(4): 474-478
Kreitchmann, R.; Innocente, A.P.; Preussler, G.M.I. 2012: Safety and efficacy of contraceptive implants for HIV-infected women in Porto Alegre, Brazil International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 117(1): 81-82
Frank, M.L.; Ditmore, J.R.; Ilegbodu, A.E.; Bateman, L.; Poindexter, A.N. 1995: Characteristics and experiences of American women electing for early removal of contraceptive implants Contraception 52(3): 159-165
Bisio, F.; Nicco, E.; Calzi, A.; Giacobbe, D.R.; Mesini, A.; Banguissa, H.; Vividila, N.E.; Mahoungou, P.él.; Boumba, J.D.; Mboungou, F.A.M.; Bruzzone, B.; Ratto, S.; Icardi, G.; Viscoli, C.; Bruzzi, P. 2015: Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo New Microbiologica 38(2): 185-192
Ramachandran, G.; Kumar, A.K.H.; Vasantha, M.; Shah, I.; Swaminathan, S. 2010: Plasma efavirenz in HIV infected children treated with generic antiretroviral drugs in India Indian Pediatrics 47(10): 890-891
Pyra, M.; Heffron, R.; Mugo, N.R.; Nanda, K.; Thomas, K.K.; Celum, C.; Kourtis, A.P.; Were, E.; Rees, H.; Bukusi, E.; Baeten, J.M. 2015: Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy Aids 29(17): 2353-2359